Komrokji RS - Search Results

1

Oxaliplatin-induced immune mediated thrombocytopenia.

Beg MS, Komrokji RS, Ahmed K, Safa MM. Beg MS, et al. Among authors: komrokji rs. Cancer Chemother Pharmacol. 2008 Oct;62(5):925-7. doi: 10.1007/s00280-007-0675-5. Epub 2008 Jan 19. Cancer Chemother Pharmacol. 2008. PMID: 18204841

2

Male breast cancer in the veterans affairs population: a comparative analysis.

Nahleh ZA, Srikantiah R, Safa M, Jazieh AR, Muhleman A, Komrokji R. Nahleh ZA, et al. Cancer. 2007 Apr 15;109(8):1471-7. doi: 10.1002/cncr.22589. Cancer. 2007. PMID: 17342768 Free article.

3

Outcome of patients with myelodysplastic syndromes in the Veterans Administration population.

Komrokji RS, Matacia-Murphy GM, Al Ali NH, Beg MS, Safa MM, Rollison DE, List AF. Komrokji RS, et al. Leuk Res. 2010 Jan;34(1):59-62. doi: 10.1016/j.leukres.2009.03.022. Epub 2009 Apr 14. Leuk Res. 2010. PMID: 19368972

4

Outcome of esophageal carcinoma in the veteran affairs population: a comparative analysis from the Veteran Affairs Central Cancer Registry.

Beg MS, Navaneethan U, Atiq M, Komrokji R, Safa M. Beg MS, et al. Am J Clin Oncol. 2009 Jun;32(3):286-90. doi: 10.1097/COC.0b013e31818af0d8. Am J Clin Oncol. 2009. PMID: 19433959

5

Phase II trial of thalidomide, irinotecan and gemcitabine in chemonaive patients with advanced non-small cell lung cancer.

Jazieh AR, Komrokji R, Gupta A, Patil S, Flora D, Knapp M, Issa M, Abdel Karim N. Jazieh AR, et al. Cancer Invest. 2009 Nov;27(9):932-6. doi: 10.3109/07357900801944856. Cancer Invest. 2009. PMID: 19832041 Clinical Trial.

6

Outcome of diffuse large B-Cell lymphoma in the United States has improved over time but racial disparities remain: review of SEER data.

Komrokji RS, Al Ali NH, Beg MS, Safa MM, Rollison D, Kharfan-Dabaja M, Bello C, Cultrera J, Sokol L, Pinilla-Ibarz J, Sotomayor EM. Komrokji RS, et al. Clin Lymphoma Myeloma Leuk. 2011 Jun;11(3):257-60. doi: 10.1016/j.clml.2011.03.012. Epub 2011 Apr 20. Clin Lymphoma Myeloma Leuk. 2011. PMID: 21658652

7

Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromes.

Garcia-Manero G, Montalban-Bravo G, Berdeja JG, Abaza Y, Jabbour E, Essell J, Lyons RM, Ravandi F, Maris M, Heller B, DeZern AE, Babu S, Wright D, Anz B, Boccia R, Komrokji RS, Kuriakose P, Reeves J, Sekeres MA, Kantarjian HM, Ghalie R, Roboz GJ. Garcia-Manero G, et al. Among authors: komrokji rs. Cancer. 2017 May 15;123(6):994-1002. doi: 10.1002/cncr.30533. Epub 2017 Jan 17. Cancer. 2017. PMID: 28094841 Free PMC article. Clinical Trial.

8

Mini-BEAM and autologous hematopoietic stem-cell transplant for treatment of post-transplant lymphoproliferative disorders.

Komrokji RS, Oliva JL, Zand M, Felgar R, Abboud CN. Komrokji RS, et al. Am J Hematol. 2005 Jul;79(3):211-5. doi: 10.1002/ajh.20334. Am J Hematol. 2005. PMID: 15981226 Free article.

9

Therapy related CMML: a case report and review of the literature.

Ahmed F, Osman N, Lucas F, Neff G, Smolarek T, Bennett JM, Komrokji RS. Ahmed F, et al. Among authors: komrokji rs. Int J Hematol. 2009 Jun;89(5):699-703. doi: 10.1007/s12185-009-0318-1. Epub 2009 May 9. Int J Hematol. 2009. PMID: 19430863 Review.

10

Validation of International Working Group response criteria in higher-risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium.

Komrokji RS, Al Ali NH, Sallman D, Padron E, DeZern AE, Barnard J, Roboz GJ, Garcia-Manero G, List A, Steensma DP, Sekeres MA. Komrokji RS, et al. Cancer Med. 2021 Jan;10(2):447-453. doi: 10.1002/cam4.3608. Epub 2020 Dec 22. Cancer Med. 2021. PMID: 33350168 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

343 results

Search Page

Filters